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The aim of this paper is to contribute to debates about how governments and other stakeholders can influence the
application of ICTs to increase access to safe, effective and affordable treatment of common illnesses, especially by
the poor. First, it argues that the health sector is best conceptualized as a ‘knowledge economy’. This supports a
broadened view of health service provision that includes formal and informal arrangements for the provision of
medical advice and drugs. This is particularly important in countries with a pluralistic health system, with relatively
underdeveloped institutional arrangements. It then argues that reframing the health sector as a knowledge
economy allows us to circumvent the blind spots associated with donor-driven ICT-interventions and consider
more broadly the forces that are driving e-health innovations. It draws on small case studies in Bangladesh and
China to illustrate new types of organization and new kinds of relationship between organizations that are
emerging. It argues that several factors have impeded the rapid diffusion of ICT innovations at scale including: the
limited capacity of innovations to meet health service needs, the time it takes to build new kinds of partnership
between public and private actors and participants in the health and communications sectors and the lack of a
supportive regulatory environment. It emphasises the need to understand the political economy of the digital
health knowledge economy and the new regulatory challenges likely to emerge. It concludes that governments
will need to play a more active role to facilitate the diffusion of beneficial ICT innovations at scale and ensure that
the overall pattern of health system development meets the needs of the population, including the poor.
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The rapid pace of mobile phone adoption, with its
promise of universal connectivity, lends credence to
beliefs that the latest generation of information and
communication technologies (ICTs) will support
substantial beneficial changes in the organisation of
the health sector [1–3]. This has led donor agencies
and foundations to invest in many digital health inter-
ventions in low and middle-income countries, in the
hope that they will provide a way to address major
deficiencies in access to safe, effective and affordable
health services, especially by the poor [4]. It has also
stimulated large private sector investments in pursuit
of niches in rapidly changing markets.* Correspondence: G.Bloom@ids.ac.uk
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It then argues that reframing the health sector as a
knowledge economy allows us to circumvent the
blind spots associated with donor-driven ICT-
interventions and consider more broadly the forces
that are driving e-health innovations.
The subsequent section presents the findings of
studies of digital health in Bangladesh and China, which
explore how the information and health sectors are
responding to the changing technological possibilities.
These are small scale studies of different aspects of
digital health in each country. They offer an opportunity
to explore how information and health sector innova-
tions are opening up possibilities for reconfiguring the
delivery of outpatient health advice and treatment. These
explorations also raise fundamental questions about
regulation and governance to protect the interests of the
poor and ensure that health information remains at the
service of public health. The paper concludes with a dis-
cussion of the role of governments in supporting and in-
fluencing the direction of development of ICT-enabled
health systems.
Knowledge asymmetries and the health sector
We view the health sector as a knowledge economy,
which makes widely available the benefits of expert med-
ical knowledge and specialised commodities, such as
pharmaceuticals [7]. Although many spheres of
economic activity involve asymmetries of knowledge and
expertise between providers and consumers, the health
knowledge economy has unique characteristics because
of the potentially deleterious consequences of an ill-
informed response to a health challenge for an individual
and/or a community. This bestows power on possessors
of health-related expertise and a risk that they will abuse
this power [8, 9]. To redress this imbalance, societies
have evolved institutional arrangements to ensure that
experts are competent and limit the degree to which cer-
tified experts can use their power for personal or corpor-
ate gain. These arrangements include self-regulating
professions, watchdog organisations, and professional
regulatory bodies. The state also commonly funds re-
search, training of medical experts and provision of
some health services. The existence of extra-market ar-
rangements for protecting the public good is a charac-
teristic of an effective health sector. The way these
arrangements function is strongly influenced by the in-
terests and understandings of users, providers, gate-
keepers and by the context of broader configurations of
power and expertise. This understanding of a health
knowledge economy shifts analysis away from the im-
pact of individual digital health interventions towards an
examination of the way that new technologies and the
actors behind them are beginning to disrupt theseconfigurations both globally and locally and the potential
consequences for large-scale change.
This paper focuses on low- and middle-income
countries with a pluralistic health sector, where gov-
ernance and institutional arrangements are much
less entrenched than in the advanced market econ-
omies [7, 10]. During the twentieth century the lat-
ter countries experienced significant political debate
about the organisation of their health sectors. They
created institutional arrangements to protect their
population against major health shocks and provide
access to safe, competent and trustworthy care.
These arrangements represent political agreements
that have become deeply embedded in their society
and are, therefore, difficult to change [11–13]. Some
analysts have argued that the relative newness of the
so-called “emerging markets”, especially around the
telecommunications and health sectors, mean that
they face fewer constraints to the emergence and
rapid spread of new kinds of organisation supported
by ICTs [14, 15].From digital health interventions to the evolution
of health knowledge economies
Both the use of mobile phones and access to the internet
have increased rapidly over the past decade in low- and
middle-income countries.1 This has stimulated many
local applications of information technology in the
management of health facilities and programmes, the
provision of information and advice to health workers
and patients and the strengthening of links between
front-line health services and more highly qualified doc-
tors [16]. However, a recent study, which included inter-
views with key informants in the digital health
community, reported that very few could identify many
examples of digitally-enabled health service innovations
that successfully went to scale [17]. Systematic reviews
of different types of ICT-supported health intervention
in low- and middle-income countries, funded by donors
or foundations, have all reached similar conclusions
about the outcomes of these interventions [18–23]. The
small number of available evaluations has mostly shown
the feasibility of interventions that address a narrowly
defined health issue, such as improving the coverage of
ante-natal services or the timeliness of routine immuni-
zations. A small number have demonstrated improve-
ments in decision-making by health workers or the
general public. Even fewer have demonstrated impact on
health services and/or health outcomes at scale [21].
This is partly because of a lack of good quality studies,
but it also reflects the complex process through which a
series of technological innovations can ultimately lead to
major changes in a sector’s organisation. Expectations
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seem to have been unrealistic.
Analysts have argued that evaluations of ICT-
enabled health interventions need to shift from test-
ing whether an innovation has a direct effect on
health outcomes to exploring the wider impact of
ICT solutions on alleviating health system constraints
and improving performance [16]. A recent paper
follows the World Health Organization (WHO) in de-
fining a health system as “all activities whose primary
purpose is to promote, restore or maintain health”
and identifies several functions that digital health
interventions have addressed [4]. It argues that health
systems can incorporate applications that address
critical constraints that impair their performance.
Although this approach offers insights into the possi-
bilities afforded by digital health, its focus on the nor-
mative and technical components of a health system
doesn’t adequately consider two important aspects of a
health knowledge economy: the sets of social, economic
and political interests which shape processes and out-
comes; and the large array of informal and external rela-
tionships, commodities and services, which provide
health-related information, advice or treatments.
The way an analyst frames a system and the boundary
he or she draws around its constituent parts influences
both the topics of analysis and the policy options consid-
ered [24]. Using a health knowledge economy lens
means that a more inclusive boundary can be drawn. It
frames the health system to include all actors that
provide knowledge and advice or specialised medical
commodities to the population and takes into account
user and market driven ICT practices. This has two con-
sequences. First, it includes individuals and organisations
within and outside the system of formal provision. This
is important in a pluralistic health system, where many
people seek advice and buy pharmaceuticals from drug
stores, or service providers working outside the regula-
tory framework [7, 25]. Second, it draws attention to the
increasing involvement in the health sector of informa-
tion and communications organisations such as mobile
phone operators, local ICT entrepreneurs, advertising
agencies and large knowledge companies.
Technological developments are enabling the emer-
gence of new types of organisation and new forms of
partnership and network that cross the boundaries
between the health, knowledge and communications
sectors, stimulated by several demand and supply-side
factors [1, 14, 26]. More people are living with chronic
conditions without much support from the formal health
system, especially in low- and middle-income countries
[2, 27, 28]. The development of evidence-based treat-
ment guidelines that link symptoms, diagnostic tests and
basic treatment may be stimulating a shift from “medicaldominance” to “managed consumerism” with people tak-
ing more responsibility for their own “health mainten-
ance” in the advanced market economies [29]. Also, new
forms of corporate organisation of health service
delivery have become increasingly prominent [30–32].
The development of communications media, especially
mobile phones, is creating a way to provide low-cost
access to expert knowledge and advice, and the develop-
ment of mobile phone payment mechanisms is making
innovative business models easier to implement.
According to Schmit and Cohen [33], the explosive
increase in access to mobile phones and the internet
by relatively poor people in low- and middle-income
countries is creating new business opportunities and
generating new regulatory challenges. In many of
these countries, a high proportion of economic
transactions takes place outside a formal regulatory
framework [34]. Meanwhile, large corporations from a
number of countries, including China and India, are
establishing a global presence. A recent report by
Dobbs et al. [15] argues that these countries are
becoming sources of disruption of global markets
because of the rapidly rising demand for services as-
sociated with economic growth and urbanisation and
their less entrenched institutional arrangements.
Despite these possibilities, recent reviews have shown
that progress by private service delivery organizations
in meeting health-related demands has been limited
[35] and the spread of digital health services has been
modest [3]. The following section presents informa-
tion from Bangladesh and China, which shows that
new types of organisation and partnership are emer-
ging, which may eventually create the possibility of
change at scale.
Bangladesh and China: New intermediaries, new
dynamics?
Bangladesh and China have pluralistic health systems
with big differences between urban and rural areas in
the availability of good quality and trusted health facil-
ities. Both countries have high levels of mobile phone
coverage, a dynamic ICT sector and governments that
are encouraging the development of this sector. There
are also significant differences. China has experienced
sustained economic growth over many years leading to a
dramatic fall in poverty and rapid increases in disposable
income. It is implementing a series of reforms aimed at
strengthening government health services. It has large
and well-established companies in both the pharmaceut-
ical and information sectors, which are increasingly
engaged in global markets. Bangladesh is typical of a
number of low-income countries, with a much smaller
internal market and very few companies with a global
reach, although it has a well-established national
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vice infrastructure and major health service delivery
NGOs. It also has growing capacity in software develop-
ment and applications. Its e-health sector largely
depends on international donors and foundations for
investment finance [36].
Digital health innovations in the Bangladesh health sector
The data on Bangladesh are derived from a mapping and
review of 26 e-health interventions in 2012 [37], a series
of in-depth interviews with e-health innovators in Dhaka
as part of a broader study of innovations and health sys-
tem change in Bangladesh [36] and a survey of 800
households in rural and urban localities to study health
information seeking behaviour and weighted towards
lower income households [38]. These studies describe a
variety of actors and emergent partnerships and net-
works. The Ministry of Health has established an e-
health administrative unit, which is integrating ICTs into
planning and management and establishing a telephone
medical advice line. Several start-up companies have de-
veloped ICT applications and different knowledge inter-
mediaries provide information on health issues on a
website or in SMS messages. These intermediaries in-
clude large NGOs, research institutes, social businesses
and private entrepreneurs based within and outside
Bangladesh. These initiatives are mostly funded by
grants from donor agencies or foundations. The study
found several innovative partnerships and networks.
One m-health company had linked to local (untrained)
village doctors/drug sellers to offer a package of basic
services. Another had partnered with a very large service
delivery NGO and a national retail chain to create a
website on maternal and child health and send SMS
messages to pregnant women. Another national retail
chain had established a health website and advice line,
linked to an online shop. Several mobile phone
operators had launched health advice lines. The study
found that company leaders were enthusiastically
seeking a niche in what they perceived to be a poten-
tially large market in the future. However, the only ones
that were financially secure were linked to an established
retail chain or mobile phone operator.
The household survey found that only a tiny
proportion of people had actually used their mobile
phones to seek health information and there was little
awareness of websites with health information or
SMS health messages [38]. The situation was different
for college students, a significant proportion of whom
used mobile phones to seek information on sexual
health or physical appearance, relying especially on
Facebook as a source of information and advice [39].
There were significant differences in the way that
men and women used phones to access information,reflecting underlying gender relationships and power
dynamics within households. In particular, women’s
access to phones was often mediated by family gate-
keepers such as husbands and fathers who controlled
both the finance and the social interactions that wives
and daughters were allowed.
Overall, there was a lot of innovative activity in
Bangladesh, mostly financed by non-commercial innovation
grants and internal investments by established companies.
Some promising partnerships were emerging and several
companies were developing an online presence, but there
had been little substantial impact on the way that most
people manage their health problems.
Private investment in digital health in China
The information on China comes from a scoping study
of the digital health sector by (Guo Z. Implication of
mHealth Development and Application to the China
Health Reform, unpublished). This consisted of a review
of published data, online news and information sources
and the websites of companies involved in the sector.
The study found a very sharp increase in e-health invest-
ments, reaching 15.75 billion RMB ($2.5 billion) in 2015.
The turnover is projected to reach 2.5 billion rmb a year
by 2017. One major area of investment is in the online
supply of pharmaceuticals. This has been stimulated by
government efforts to reduce the incentives for health
facilities to encourage excessive use of drugs by ending
their ability to earn a profit from supplying these prod-
ucts [40]. Organizations developing these online services
include pharmaceutical manufacturers, pharmaceutical
retail chains and very large online shopping platforms.
At least one of these shopping platforms has acquired a
retail pharmacy chain. Chinese law defines a category of
drugs that can only be supplied on a doctor’s prescrip-
tion, which some online platforms have circumvented by
employing doctors, or ignoring the law [41]. Companies
are also lobbying for a change in the regulatory frame-
work to permit electronic prescriptions. This would fa-
cilitate the creation of new types of relationship between
health facilities and pharmaceutical suppliers. An article
in the China Daily [42], posted on the website of the
State Council, indicated that government is considering
this kind of change. However, there has been little move-
ment since then, suggesting that the decision is con-
tested. The ultimate decision will strongly influence
future developments, since it could open access to a very
large market.
A second area of business is the provision of online
medical advice services. One example is Spring Rain
Doctor, which provides online consultations with a
doctor. It is also creating an algorithm-driven electronic
advice service. In 2015 it claimed to have 45 million
users who posted about 60,000 medical queries a day
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vices to monitor health metrics and enable people to
manage their fitness or their control of a health prob-
lem. One example is a platform to support people
with diabetes, which includes the use of a device to
monitor blood sugar.
The rise in investment in digital health is so recent
that it is difficult to know whether it reflects the
opening up of big business opportunities or a short-
term bubble, with inflated statements of investment
commitments. The number of companies involved
and the size of proposed investments suggest the
former. The government has stated its support for
e-health, but many issues are being negotiated. These
include the legalisation of electronic prescriptions, the
establishment of an enforceable framework to regulate
the quality of diagnostic devices and of the advice
provided and the development of links between digital
health services and government health facilities. The
size of China’s health care market is big and if digital
health services become firmly established, Chinese
firms would have great possibilities for taking these
services abroad.
Bangladesh and China illustrate the degree to which
new actors are becoming involved in the health
knowledge economy. In Bangladesh, mobile phone
operators, retail chains selling health-related commod-
ities and large service delivery NGOs have built
partnerships with small tech start-up companies.
Facebook has become an important source of health
information amongst the young. In China, large
pharmaceutical manufacturers and retailers and
internet platforms are playing a leading role. There
are also a large number of tech start-ups. There is
evidence of new kinds of partnership that link
organisations that (i) provide expert advice using
trained professionals and/or treatment guideline
algorithms, (ii) give access to low cost diagnostic
technologies, such as testing for blood sugar, and (iii)
have the capacity to supply drugs and health-related
commodities. Despite the many developments
described above, the impact of ICTs on the organisa-
tion and performance of health knowledge economy
of these countries has, to date, been limited.
Discussion
Are ICTs disrupting the health knowledge economy?
A senior official of a donor agency recently asked one
of the authors whether their agency should take
digital health into account in the provision of support
for health system strengthening. There is no simple
answer to this question. As discussed above, most
donor-funded investments in digital health have not
yielded big health benefits. However, the studies inBangladesh and China found evidence of a variety of
emergent organisations, inter-organizational relation-
ships and business models, suggesting the possibility
of future changes at scale. Elsewhere too, the growing
tendency of large American internet companies to
offer health-related services, in the form of fitness-
related devices, systems to support people with
chronic illnesses and so forth, indicates their recogni-
tion of potentially big business opportunities.
We suggest that the relatively slow development of
digital health reflects the following special character-
istics of the health knowledge economy. First, a use-
ful health service in a country like China or
Bangladesh needs to include a combination of diag-
nosis, expert advice and drugs. This is likely to in-
volve relationships between organisations with
different roles, responsibilities and values in the
health and communication sectors. Second, health
systems often combine public funding of some ser-
vices with out-of-pocket payment for others, so that
business models need to combine funding from mul-
tiple sources. Third, well-functioning health systems
must be embedded in institutional arrangements for
accountability and efforts to reshape markets and as-
sociated regulatory frameworks are complex and pol-
itically charged. The need to achieve progress on
each of the above, has reduced the speed with which
new technological possibilities have been translated
into large-scale changes in the way health services
are organised [1].
Debates about the desirability of further investment
in digital health reflect the different time horizons
and attitudes to risk of large ICT companies, venture
capital funds, donor agencies and governments. Some
large companies take a long view aimed at creating a
niche in a rapidly changing economy and are not
afraid to incur significant losses in the short term.
For example, Google invested heavily in creating
detailed city maps, to produce a digital infrastructure.
Other companies have experienced losses, whilst
building an enormous customer base, which eventu-
ally generated profits. A number of companies are
investing to establish future positions in the health know-
ledge economy. Donor agencies and governments, on the
other hand, have a shorter time horizon, preferring
low-risk investments likely to yield immediate bene-
fits. Recent efforts to coordinate donor investments in
digital health reflect the beginnings of a strategic
shift, with mechanisms such as the Health Data
Collaborative (HDC) and USAID’s Digital Health
Initiative emerging to support country-level capacity
development [44]. However, these initiatives have
largely focused on public sector developments. We
argue that governments and donor agencies need to
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in the health knowledge economy to support develop-
ments in the public and private sectors that build
local capacity and meet the needs of the poor [45].
Regulatory challenges in the health knowledge economy
The developments described above pose big regulatory
challenges and governments need to modify and
strengthen institutional arrangements to address them.
This will involve changes to regulations that block the
development of potentially beneficial services. For
example, there may be rules that reserve the right to
provide advice on the use of many drugs to a licensed
doctor, even though large numbers of people buy these
products from local drug sellers without a prescription. It
will also involve additions to the regulatory framework.
One challenge arises from the increasing use of
treatment guidelines. This builds on previous invest-
ments by the governments of several advanced market
economies to support the generation and synthesis of
knowledge to inform evidence-based medical care.
This knowledge has been incorporated into diagnosis
and treatment guidelines in text books and manuals
used by providers of medical care and increasingly by
the general public. The use of guidelines for a
growing number of treatment decisions is diminishing
the role of clinical judgement in the management of
many common health problems [29]. This is likely to
reduce the capacity of doctors to control the use of drugs
for these conditions. Other approaches will be needed to
encourage people to use them appropriately.
The translation of treatment guidelines into com-
puterized decision-making algorithms is increasing
their influence. Algorithms that provide advice on the
basis of answers to simple questions and diagnostic
information, such as blood pressure, temperature and
blood sugar can substantially increase the ability of
people to make use of treatment guidelines. Their
incorporation into easy-to-use smartphone apps will
further simplify their use.
The producers of algorithms can influence the deci-
sions of many people. Their underlying assumptions,
cultural understandings and financial interests are
likely to affect the content of the algorithms [46]. For
example, if the questions an algorithm asks and the
data it uses focus on the relationship between
pharmaceutical treatment and health, it will provide
advice on the choice and dosage of drugs, but not on
other factors that influence health, such as diet,
lifestyle and exposure to environmental toxins. This
could lead to an excessive reliance on drugs to
control risk factors for non-communicable diseases.
Another example is the establishment of a new diagnosis.
This could have major financial implications if it were tojustify a particular treatment regime [47, 48]. In some
cases, pharmaceutical companies have attempted to influ-
ence the definition of a diagnosis as a strategy for creating
markets for their products [49]. This applies especially to
the growing number of “lifestyle”-related uses of pharma-
ceuticals for altering moods, increasing libido, building or
losing weight, increasing athletic performance and so
forth. The boundary between “lifestyle” and “medical”
decision-making algorithms is becoming increasingly diffi-
cult to define in the face of the rising burden of chronic
non-communicable diseases, including mental illness, and
of measures to reduce symptoms and control risk-factors,
such as hypertension.
The public domain has tended to lead the develop-
ment of treatment guidelines, with a substantial
involvement of organised medical professions and
training and research institutions. The character of
many digital health applications, in contrast, is largely
opaque. A study of the top-rated medical and health
applications available through Apple’s App store
reveals that most make unsubstantiated claims to
medical authority, leaving both expert and lay users
in the dark about where the information and advice they
provide is derived from and whether the producers of the
applications have links with companies that sell pharma-
ceuticals or diagnostic equipment [50, 51].
Two developments are likely to increase the import-
ance of health-related algorithms and the governance
challenges associated with them. The first concerns the
increasing availability of low-cost diagnostic technologies
in the form of smartphone and computer attachments
or standalone devices meant to be used by patients,
front line medical staff or other suppliers of drugs and
health-related commodities. The second concerns
automated processes for updating the content of original
algorithms on the basis of incoming data (machine
learning). The continuous collection of data that links
indicators, such as blood pressure and blood sugar to
specific treatments creates the possibility of collecting a
large body of data that could guide future treatment
regimens. This raises issues regarding the accuracy of
the data collected and also the specific “research” ques-
tions that drive the data collection. The organisations
that own the data and use them to revise algorithms will
accrue increasing influence.
The availability of health-related algorithms could be-
come especially important in countries with pluralistic
health systems, where people take a lot of responsibility
for their own health care and access to trustworthy treat-
ment guidelines could be particularly useful [28, 52].
However, inappropriate guidelines or apps aimed at gener-
ating new markets for pharmaceuticals or diagnostic
equipment pose a particular risk in these countries due to
poor regulation and lack of consumer protection. Lewis
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combination of usage scenarios, contextual factors and
app complexity to assess the risk of harm from a so-called
health app.
There are a variety of potential regulatory approaches
for addressing these issues. Some health problems may
be relatively minor and regulators could follow a strategy
of “buyer beware” by strengthening consumer protection
and focusing regulations on informing the public about
the contents of any products and preventing false and
misleading claims. In other cases, major deleterious con-
sequences could arise from the provision of misinforma-
tion and inappropriate treatment, making information
asymmetry an important consideration. Governments
and organised professional and expert bodies have an
important role to play in these cases. This may involve
the development of treatment guidelines and algorithms
as national or global public goods to be made available for
use by both public and private health service providers.
Alternatively, it may be appropriate to regulate the
production and use of treatment algorithms.
Mechanisms are needed to ensure that the organised
professions and the medical and nursing schools
associated with them, pharmaceutical companies and
newer entrants in the health knowledge economy are
accountable for the advice they provide. This will
require strong strategic leadership by national govern-
ments and international organisations.
In China and Bangladesh, the links between providers
of medical advice and treatment and suppliers of
pharmaceuticals are complex. In Bangladesh, informal
village doctors and drug sellers, working outside the
regulatory framework, are important sources of both
advice and treatment, especially for the poor. In that
country, there have been several attempts to link a
digital health company with village doctors, as a means
of improving the practice of the latter. In China, where
the formal retail sector developed rapidly since the be-
ginning of the transition to a market economy in the
1980s, several online shopping companies are now mak-
ing large investments to establish links with local shops
and create a capacity to make next-day deliveries. These
examples illustrate how companies can use information
technologies to enable people to link to a network of
small businesses, which can supply goods and services.
This kind of network that links local suppliers of phar-
maceuticals to a source of treatment algorithms and a
means for monitoring drug quality could provide a low-
cost way to meet health care needs of the relatively poor.
It might involve an internet platform and pharmaceut-
ical wholesalers and retailers. But, there are governance
risks concerning the management of conflicts of interest
between those of clients, who are seeking evidence-
based and cost-effective ways to deal with healthproblems, and businesses, whose revenues depend on
the volume of sales of pharmaceuticals and diagnostic
devices. Governments will need to play new and challen-
ging stewardship roles as these changes go to scale.
Strengthening public health in the interests of the poor:
Supporting transitions in the health knowledge economy
The Bangladesh and China cases illustrate the different
kinds of organisation that are becoming involved in the
health knowledge economy and the variety of new kinds
of partnership that are being established. It is possible to
envisage quite different pathways of development as new
possibilities for organising access to health services have
impact at scale. Some pathways could result in big
increases in access to appropriate advice and effective
treatment. Others, however, could reflect the interests of
powerful stakeholders, such as the producers and
distributors of diagnostic tests and drugs, and encourage
unnecessary use of these products. The “choice” of
development pathways will be strongly influenced by
political factors and the actions of government and other
stakeholders to establish new kinds of partnership and
reform the regulatory framework.
Developments in the broader knowledge economy are
likely to influence the health knowledge economy. In the
past 20 years a number of information companies have
grown very quickly to take advantage of short-term
monopoly positions, becoming very large corporations
that combine provision of access to the internet, produc-
tion of knowledge content and the diffusion of content
through the mass media [54, 55]. Other companies like
Google, Facebook, Amazon and Alibaba have become
actors in political negotiations about the shape of know-
ledge industry markets [56–58]. These companies are
seeking niches in the health knowledge economy and
will eventually establish relationships with organisations
that deliver health services and supply health-related
commodities. This opens up the possibility of the emer-
gence new types of powerful organisation that seek to
influence the regulatory framework.
In China, pharmaceutical producers, retail pharmacy
chains and large online shopping platforms are making
substantial investments to develop digital health services.
They are engaging with the organised health system and
health regulatory agencies to influence the institutional
arrangements. In Bangladesh, retail chains are building
their presence in a market place that is changing more
slowly, certainly in terms of consumer demand. Much of
the investment in Bangladesh has been in the form of
grants by donor agencies to relatively small ICT
companies and by mobile phone operators seeking
added-value lines of business. As Bangladesh’s consumer
base increases with economic growth, these increased
market opportunities are likely to attract larger players
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portant trend is the increasing role of digital platforms
as intermediaries between different stakeholders. In
China and Bangladesh, health sector intermediaries in-
clude websites of existing brick-and-mortar suppliers of
drugs and health-related products, telemedicine plat-
forms and online platforms that offer a wide variety of
goods and services. These intermediaries are likely to
gain influence as gatekeepers to information and advice.
Conclusions
Christensen et al. [1] argue that a major health system
transition entails the creation of a new “value network”.
By that they mean organisational structures and regula-
tory arrangements that make possible the rapid growth
of new types of service delivery organisation, the cre-
ation of new kinds of relationship between health sector
organisations and between them and health financing
agencies. Wilson et al. [26] make a similar argument in
advocating that investments in digital health should de-
fine “institutionalization” as an appropriate goal. They
suggest that all stakeholders involved in the ICT-enabled
health sector in low- and middle-income countries need
to build a common vision for achieving this goal and
that governments and funding agencies should support
investments to achieve the vision. We agree with these
reflections but suggest that more attention should be
paid to the influence of conflicts of interest and unequal
power relationships on the direction of change. Castells
[55] emphasises the influence of the coordinating and
regulatory functions of the state and argues that the
networks of power constructed around the state play a
fundamental role in the overall pattern of development
of the knowledge economy. This includes the efforts by
some stakeholders to increase their competitive
advantage by influencing regulatory arrangements in
ways that could conflict with the interests of the public
[5]. For example, they could oppose regulations meant
to ensure that providers of medical advice do not have a
financial interest in promoting high levels of drug use.
Governments already play an important role in most
countries’ health sector. They will need to play an active
role in shaping health knowledge economy markets and
ensuring that the interests of citizens, particularly the
poor and politically weak, are represented. Otherwise
there is a risk that new value networks will respond
largely to the interests of the better off and of the
suppliers of health-related goods. There is a need for
more work on mapping the participants in the health
knowledge economy and their strategies for building
market share to inform debates about regulatory reform.
Governments, donor agencies and foundations need to
reassess their strategy for supporting digital innovation
in the health sector to take the above considerations intoaccount. There is still a need for investment in innova-
tions that address specific health and health service
needs. However, this needs to be complemented by
strategic investments in the establishment of partner-
ships and networks that have the capacity to use innova-
tive approaches to meet the health needs of poor clients
at scale. Other measures are needed to strengthen the
capacity of government and other stakeholders to play
an effective regulatory and stewardship role. This may
include investment in the creation of algorithms for
treatment of common health problems and the supply of
them to potential health intermediaries, regulation of
cross-sector ownership to reduce the incentives to
oversupply drugs or diagnostic tests and new kinds of
national and global regulation of the provision of
medical advice. The lessons from other sectors suggest
that once a tipping point is reached, the process of
change can be very rapid. Governments need to engage
actively in the innovation process, assess potential risks
and set in place strategies to mitigate these risks as digital
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